Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | (FY)Mar 31, 2016 | (FY)Mar 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 50.96%2.14B | -22.87%1.41B | 44.82%1.83B | 19.88%1.27B | -6.98%1.06B | 17.01%1.14B | -26.66%970.83M | 3.18%1.32B | -24.81%1.28B | 0.69%1.71B |
Net profit before non-cash adjustment | 50.18%1.9B | -16.92%1.26B | 11.01%1.52B | 7.83%1.37B | -21.91%1.27B | 573.24%1.63B | -78.91%241.43M | -31.66%1.14B | -7.00%1.68B | 29.02%1.8B |
Total adjustment of non-cash items | 1,452.92%308.45M | -103.10%-22.8M | 1,127.80%734.83M | -210.65%-71.5M | 121.20%64.61M | -127.72%-304.78M | 744.75%1.1B | 22.54%130.16M | 186.78%106.22M | -936.12%-122.39M |
-Depreciation and amortization | 3.14%231.62M | -32.66%224.57M | 18.56%333.48M | -0.97%281.29M | 0.01%284.03M | 5.33%284.01M | -5.98%269.64M | 0.11%286.79M | 3.08%286.47M | -2.04%277.89M |
-Reversal of impairment losses recognized in profit and loss | -39.40%142.29M | -61.82%234.81M | 117.21%615.05M | 166.19%283.15M | 20.24%106.37M | 24.64%88.46M | 23.83%70.97M | -24.97%57.32M | -17.88%76.39M | -69.11%93.02M |
-Assets reserve and write-off | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 331.61%14.9M | 101.74%3.45M |
-Share of associates | 173.99%15.25M | 120.39%5.56M | 65.58%-27.28M | -242.79%-79.26M | 92.91%-23.12M | -135.14%-326.05M | 1,819.42%927.9M | --48.34M | ---- | ---- |
-Disposal profit | -10.97%-201.21M | -66.27%-181.31M | -565.67%-109.05M | 143.90%23.42M | 78.45%-53.34M | -26.27%-247.55M | 22.66%-196.04M | -6.47%-253.49M | 14.94%-238.08M | -73.73%-279.88M |
-Net exchange gains and losses | 53.88%-8.64M | -54.92%-18.74M | -199.38%-12.1M | -142.93%-4.04M | 125.64%9.41M | -208.05%-36.71M | 165.81%33.97M | -212.09%-51.62M | 146.42%46.05M | -139.28%-99.2M |
-Remuneration paid in stock | --7.31M | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Pension and employee benefit expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -9.24%20.8M | --22.92M |
-Other non-cash items | 142.35%121.84M | -340.72%-287.69M | 88.67%-65.28M | -122.64%-576.05M | -286.51%-258.74M | -861.53%-66.94M | -116.26%-6.96M | 142.69%42.82M | 28.65%-100.31M | 16.91%-140.6M |
Changes in working capital | -138.74%-68.01M | 141.85%175.58M | -1,285.51%-419.53M | 89.07%-30.28M | -50.09%-277.09M | 50.12%-184.61M | -858.62%-370.08M | 109.79%48.78M | -1,898.93%-498.32M | -90.25%27.7M |
-Change in receivables | -979.75%-631.96M | 317.03%71.83M | 93.72%-33.1M | -646.31%-526.91M | 158.04%96.45M | 52.63%-166.19M | -222.54%-350.81M | 79.19%-108.77M | -278.80%-522.62M | -188.81%-137.97M |
-Change in inventory | -32.41%50.41M | 138.69%74.58M | -53,440.00%-192.74M | 98.73%-360K | -141.61%-28.4M | 152.33%68.27M | -1,442.09%-130.45M | 71.87%-8.46M | 61.53%-30.07M | -109.19%-78.16M |
-Change in prepaid assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -602.78%-257.11M | 251.74%51.14M |
-Change in payables | 1,332.41%342.62M | 110.47%23.92M | -149.18%-228.43M | 227.15%464.47M | -914.26%-365.28M | -77.30%44.86M | 25.29%197.65M | -65.33%157.76M | 2,163.62%455.08M | -91.78%20.1M |
-Change in accrued expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -183.21%-143.6M | 485.19%172.59M |
-Provision for loans, leases and other losses | 3,155.06%170.92M | -84.88%5.25M | -11.11%34.74M | 93.99%39.08M | 115.31%20.15M | -52.12%-131.55M | -283.94%-86.48M | ---22.52M | ---- | ---- |
-Changes in other current assets | ---- | ---- | ---- | ---6.56M | ---- | ---- | ---- | --30.77M | ---- | ---- |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -172K | |||||||||
Interest received (cash flow from operating activities) | 1.00%183.16M | -15.36%181.36M | 21.65%214.26M | 10.62%176.12M | 102.89%159.21M | -34.30%78.47M | 39.92%119.44M | -31.93%85.36M | -37.18%125.4M | 35.59%199.6M |
Tax refund paid | 26.24%-393.59M | 3.88%-533.61M | -3.59%-555.14M | -41.46%-535.91M | -81.59%-378.84M | 52.90%-208.62M | -41.28%-442.93M | 51.36%-313.51M | -9.04%-644.56M | -4.12%-591.12M |
Other operating cash inflow (outflow) | 0 | -85.01%39.8M | 1,693.12%265.42M | 1,480,300.00%14.8M | 99.99%-1K | -14.36M | 0 | 0 | -1K | 0 |
Operating cash flow | 74.65%1.93B | -37.33%1.1B | 90.83%1.76B | 10.14%921.83M | -15.59%836.96M | 53.16%991.5M | -40.91%647.35M | 43.44%1.1B | -41.91%763.8M | 3.19%1.31B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -324.30%-596.79M | 71.97%-140.65M | 21.51%-501.87M | -65.80%-639.44M | -367.37%-385.68M | 134.13%144.25M | -17.52%-422.64M | -204.08%-359.63M | 240.15%345.54M | -120.85%-246.54M |
Net intangibles purchase and sale | -30.87%-11.79M | -371.71%-9.01M | 60.68%-1.91M | -118.60%-4.86M | 82.00%-2.22M | -1,769.24%-12.34M | 68.60%-660K | -19.77%-2.1M | 33.24%-1.76M | 90.84%-2.63M |
Net business purchase and sale | -117,528.57%-82.2M | -99.53%70K | --14.94M | --0 | 106.83%32.69M | ---478.29M | ---- | ---- | ---- | ---- |
Net investment property transactions | ---- | ---- | ---- | ---- | ---- | ---- | --71.46M | ---- | ---- | ---- |
Net investment product transactions | -52.68%444.96M | 186.69%940.41M | -65.62%328.02M | -21.27%954.12M | 186.98%1.21B | -164.99%-1.39B | 368.18%2.14B | -260.04%-799.39M | 609.60%499.51M | 173.07%70.39M |
Repayment of advance payments to other parties and cash income from loans | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 14,247.36%686.23M | --4.78M | ---- |
Net changes in other investments | 39.23%-42.66M | -71.59%-70.2M | 72.58%-40.91M | -577.26%-149.22M | 49.05%-22.03M | 14.69%-43.24M | 91.20%-50.69M | -118.54%-575.95M | -125.33%-263.54M | -182.85%-116.96M |
Investing cash flow | -140.03%-288.47M | 457.22%720.63M | -225.60%-201.73M | -80.76%160.61M | 146.81%834.59M | -202.39%-1.78B | 265.70%1.74B | -279.77%-1.05B | 297.65%584.53M | -209.68%-295.74M |
Financing cash flow | ||||||||||
Net common stock issuance | --0 | ---110K | --0 | ---- | --299.96M | ---- | ---- | 0.85%-336.22M | -1,245.04%-339.09M | 105.26%29.61M |
Cash dividends paid | 11.09%-669.49M | -12.51%-752.96M | -33.24%-669.24M | -0.69%-502.29M | -0.70%-498.87M | 5.20%-495.41M | 5.82%-522.59M | 32.32%-554.91M | -92.67%-819.95M | -45.89%-425.58M |
Cash dividends for minorities | ---- | ---- | ---- | ---4.9M | ---- | ---- | ---- | ---- | ---- | ---- |
Net other fund-raising expenses | ---- | ---1K | ---- | ---- | ---- | 133.33%9.8M | -200.00%-29.4M | 1,381.60%29.4M | ---2.29M | ---- |
Financing cash flow | 11.10%-669.49M | -12.53%-753.07M | -31.95%-669.24M | -154.99%-507.19M | 59.04%-198.91M | 12.03%-485.61M | 35.94%-551.99M | 25.80%-861.73M | -193.29%-1.16B | 53.67%-395.96M |
Net cash flow | ||||||||||
Beginning cash position | 15.52%8.11B | 14.72%7.02B | 10.46%6.12B | 35.76%5.54B | -23.32%4.08B | 51.10%5.32B | -19.25%3.52B | 4.41%4.36B | 17.98%4.18B | 10.43%3.54B |
Current changes in cash | -9.57%967.64M | 20.48%1.07B | 54.40%888.17M | -60.94%575.25M | 215.32%1.47B | -169.53%-1.28B | 324.80%1.84B | -536.91%-817.01M | -69.99%187M | 92.31%623.18M |
Effect of exchange rate changes | -52.10%9.44M | 51.42%19.71M | 198.85%13.02M | 134.22%4.36M | -135.48%-12.73M | 198.46%35.87M | -302.17%-36.43M | 722.27%18.02M | -121.05%-2.9M | 29.83%13.76M |
Cash adjustments other than cash changes | -150.00%-1K | 300.00%2K | ---1K | ---- | ---- | ---- | ---- | ---40.67M | ---- | 0.00%-1K |
End cash Position | 12.04%9.09B | 15.52%8.11B | 14.72%7.02B | 10.46%6.12B | 35.76%5.54B | -23.32%4.08B | 51.10%5.32B | -19.25%3.52B | 4.41%4.36B | 17.98%4.18B |
Free cash flow | 37.94%1.31B | -24.02%952.72M | 353.66%1.25B | -38.31%276.4M | -19.58%448.01M | 152.22%557.09M | -69.90%220.88M | 283.46%733.78M | -80.08%191.36M | -0.88%960.45M |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |